跳转至内容
Merck
CN

1605012

USP

罗氟司特

United States Pharmacopeia (USP) Reference Standard

别名:

3-(环丙基甲氧基)-N-(3,5-二氯吡啶-4-基)-4-(二氟甲氧基)苯甲酰胺, 3-环丙基甲氧基-4-二氟甲氧基-N-[3,5-二氯-4-吡啶基]-苯甲酰胺

登录并加购,请在购物车里查看协议价、货期和发货地。

选择规格

变更视图

关于此项目

经验公式(希尔记法):
C17H14Cl2F2N2O3
化学文摘社编号:
分子量:
403.21
MDL number:
NACRES:
NA.24
UNSPSC Code:
41116107
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


grade

pharmaceutical primary standard

agency

USP

manufacturer/tradename

USP

application(s)

pharmaceutical small molecule

format

neat

storage temp.

2-8°C

SMILES string

ClC1=CN=CC(Cl)=C1NC(C2=CC=C(OC(F)F)C(OCC3CC3)=C2)=O

InChI

1S/C17H14Cl2F2N2O3/c18-11-6-22-7-12(19)15(11)23-16(24)10-3-4-13(26-17(20)21)14(5-10)25-8-9-1-2-9/h3-7,9,17H,1-2,8H2,(H,22,23,24)

InChI key

MNDBXUUTURYVHR-UHFFFAOYSA-N

General description

Find answers to frequently asked questions on USP products in USP FAQs.
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including MSDS and any product information leaflets, have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Biochem/physiol Actions

罗氟司特是一种高效、口服有效的选择性磷酸二酯酶4 (PDE4) 抑制剂。
罗氟司特是一种高效、口服有效的选择性磷酸二酯酶4 (PDE4) 抑制剂,IC50 为 0.8 nM。罗氟司特具有抗炎作用,用于临床治疗COPD。

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.

Other Notes

Sales restrictions may apply.
USP issued SDS can be found here


Still not finding the right product?

Explore all of our products under 罗氟司特




历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库